Incidence, risk factors, and outcomes of delayed graft function in deceased donor kidney transplantation in a Brazilian center

Transplant Proc. 2014 Jul-Aug;46(6):1727-9. doi: 10.1016/j.transproceed.2014.05.026.

Abstract

Background: A high incidence of delayed graft function (DGF) after deceased donor kidney transplantation occurs in Brazil. The reasons for such have not been adequately studied.

Methods: We performed a retrospective cohort study of 346 kidney transplant recipients from deceased donors. DGF risk factors related to the recipient, donor, and transplantation surgery were analyzed and correlated with graft outcomes. A logistic regression analysis was used to identify independent risk factors and patient and graft survival were assessed using Kaplan-Meier curves.

Results: The incidence of DGF was 70.8% (245 cases). Our final model of multivariate analysis showed that DGF is associated (P < .05) with donor final serum creatinine (relative risk [RR], 1.84; 95% confidence interval [CI], 1.26-2.70), donor age (RR, 1.02 [1.0-1.033]), receiving a kidney from national offer (RR, 2.44 [1.06-5.59]), and need for antibody induction (RR, 2.87 [1.33-6.18]). Outcomes that were associated with DGF were longer length of hospital stay (32.5 ± 20.5 vs 18.8 ± 16.3 days; P = .01), higher incidence of acute rejection (37.8 vs 12.9%; P < .01), worse graft survival at 1 year (83.5% vs 93.9%; P < .01), and higher levels of serum creatinine at 3, 6, and 12 months (P < .05). There was no difference in patient survival and the occurrence of acute rejection did not influence the survival of patients or grafts.

Conclusion: DGF was associated with higher donor final serum creatinine, donor age, receiving a kidney from the national supply, and need for antibody induction. Most importantly, DGF was associated with worse outcomes.

MeSH terms

  • Adult
  • Age Factors
  • Antibodies, Monoclonal / therapeutic use
  • Brazil
  • Cohort Studies
  • Creatinine / blood
  • Delayed Graft Function / etiology*
  • Female
  • Humans
  • Immunosuppression Therapy
  • Incidence
  • Kidney Transplantation / adverse effects*
  • Length of Stay
  • Logistic Models
  • Male
  • Middle Aged
  • Retrospective Studies
  • Risk Factors
  • Tissue Donors

Substances

  • Antibodies, Monoclonal
  • Creatinine